Where to Buy CovaminoSoy 2.0 and CovaminoRap 2.0 Internationally

Publication date Cropenta - 15 November 2026
Looking for an international supplier of CovaminoSoy 2.0 or CovaminoRap 2.0? Discover two innovative rumen-protected protein ingredients supported by ILVO research and Schothorst Feed Research nutritional evaluation. Contact Cropenta for product specifications, bulk purchasing and international distribution enquiries.
Where to Buy CovaminoSoy 2.0 and CovaminoRap 2.0 Internationally

Where can feed manufacturers, dairy nutritionists and ingredient distributors buy CovaminoSoy 2.0 and CovaminoRap 2.0 internationally? For professional buyers, finding the right supplier involves more than obtaining a price per tonne. The nutritional characteristics, independent research, product documentation, destination country and supply conditions all influence whether a protected protein ingredient is suitable for a particular feeding programme.

Cropenta SL supports international commercial enquiries for Bypass CovaminoSoy 2.0 and CovaminoRap 2.0, two innovative rumen-protected protein ingredients developed by a Dutch producer. Both products are designed to combine substantial protection against ruminal protein degradation with high intestinal digestibility of the protein that escapes the rumen.

The underlying technology received a Silver Innovation Award at EuroTier 2026. Its nutritional evaluation includes research conducted by ILVO using rumen-fistulated cows and subsequent protein valuation by Schothorst Feed Research (SFR). This combination of technical characterisation and formulation-relevant evaluation provides professional buyers with a basis for assessing the products beyond a declared bypass percentage.

Cropenta Insight

International buyers should evaluate rumen-protected protein on the basis of digestible protein supply rather than rumen protection alone. A high rumen-undegradable protein (RUP) percentage has limited nutritional value if the protected fraction is poorly digested in the small intestine. Equally, a highly digestible protein source may not deliver the intended metabolizable protein contribution if too much is degraded in the rumen.

Bypass CovaminoSoy 2.0 and CovaminoRap 2.0 have been developed around this relationship. Cropenta helps feed manufacturers, distributors and professional livestock operations assess their technical suitability and explore international sourcing opportunities according to the intended application, destination and required quantities.

Where to Buy CovaminoSoy 2.0 and CovaminoRap 2.0 Internationally

Professional buyers looking for an international supplier of CovaminoSoy 2.0 or CovaminoRap 2.0 can contact Cropenta SL through www.cropenta.com to request product specifications, technical information or a commercial quotation.

Cropenta works with companies active in animal nutrition, including compound feed manufacturers, agricultural cooperatives, feed ingredient distributors, nutrition specialists and professional dairy operations.

International enquiries are evaluated individually. Commercial availability and delivery conditions depend on the destination country, required volume, packaging preferences, applicable regulatory requirements and logistics arrangements. A request for quotation allows these conditions to be assessed before any supply commitment is made.

Both products can be considered for incorporation into compound feed formulations or for direct supplementation in professionally formulated ruminant diets. The appropriate commercial route depends on the buyer's activities and the nutritional application.

Bypass CovaminoSoy 2.0: Protected Soybean Protein for Dairy Nutrition

Bypass CovaminoSoy 2.0 is a rumen-protected soybean protein ingredient developed to contribute to the supply of metabolizable protein and absorbable amino acids in ruminant nutrition.

The product contains approximately 458 g/kg crude protein and is manufactured using a controlled Maillard reaction involving reducing sugars. This treatment is intended to reduce protein degradation in the rumen while preserving the intestinal digestibility of the bypass fraction.

Its principal nutritional characteristics include:

  • Crude protein content of approximately 458 g/kg.
  • Calculated rumen-undegradable protein fraction of approximately 82.48%, commonly rounded to 83%.
  • Intestinal digestibility of the rumen-undegraded protein fraction of approximately 99.60%.
  • Protein degradation characterisation through ILVO in-situ research.
  • Nutritional evaluation and formulation-relevant protein values calculated by Schothorst Feed Research.

The reported RUP value is calculated from experimentally determined degradation characteristics using an assumed fractional rumen passage rate (Kp) of 6% per hour. It must not be interpreted as a direct measurement of rumen stability after 12 hours.

CovaminoSoy 2.0 may be particularly relevant where the ration requires additional digestible bypass protein. Its suitability and economic value depend on the complete ration, existing metabolizable protein supply, amino acid balance and production objectives.

CovaminoRap 2.0: Protected Rapeseed Protein as an Alternative Protein Source

CovaminoRap 2.0 is a rumen-protected rapeseed protein ingredient developed for feed manufacturers and nutritionists seeking an alternative to soybean-based protein sources.

The product contains approximately 326 g/kg crude protein and uses the same controlled protein-protection principle. Its nutritional characteristics provide a different protein concentration and amino acid contribution from those of the soybean-based product.

Its principal nutritional characteristics include:

  • Crude protein content of approximately 326 g/kg.
  • Calculated rumen-undegradable protein fraction of approximately 80.64%, commonly rounded to 80–81%.
  • Intestinal digestibility of the rumen-undegraded protein fraction of approximately 90.14%.
  • Protein degradation characterisation through ILVO in-situ research.
  • Nutritional evaluation by Schothorst Feed Research.

CovaminoRap 2.0 can provide an alternative protein ingredient where rapeseed-derived materials are permitted and where its nutritional characteristics and commercial conditions fit the ration formulation.

The decision between CovaminoSoy 2.0 and CovaminoRap 2.0 should not be based on bypass percentage alone. Crude protein concentration, intestinal digestibility, amino acid supply, metabolizable protein valuation and delivered cost all contribute to the final economic assessment.

Independent Research: ILVO and Schothorst Feed Research

One of the important considerations when purchasing rumen-protected protein internationally is the quality of the research supporting the declared nutritional values.

The Covamino 2.0 products were characterised at ILVO using rumen-fistulated cows and an extensive in-situ or in-sacco incubation protocol extending to 336 hours. This approach allows protein degradation kinetics to be determined experimentally rather than relying exclusively on simplified laboratory estimates.

The experimentally determined fractional degradation rate (Kd), together with the measured protein fractions, forms the basis for calculating rumen bypass protein at an assumed passage rate. For the reported Covamino values, the calculation uses a Kp of 6% per hour.

Intestinal digestibility of the rumen-undegraded protein fraction was evaluated separately using the mobile nylon bag technique. Schothorst Feed Research subsequently used the experimental information to calculate nutritional values relevant to ration formulation.

This distinction matters because rumen protection and intestinal digestibility describe different stages of protein utilisation. A product can show substantial resistance to ruminal degradation without necessarily providing an equivalent amount of digestible protein in the small intestine.

The ILVO and SFR evaluations characterise the ingredients and support their nutritional valuation. They do not, by themselves, establish a specific increase in milk yield, milk protein production or feed efficiency under commercial farm conditions.

Silver Innovation Award at EuroTier 2026

The Covamino 2.0 protein-protection technology received a Silver Innovation Award at EuroTier 2026, the international trade fair for professional animal farming and livestock management organised by the DLG.

The recognition highlights the innovative character of the technology and the development work behind combining rumen protection with intestinal protein digestibility.

For international buyers, the award provides additional context about the innovation, while the nutritional assessment must continue to rely on the underlying research, product specifications and formulation-relevant measurements.

Technical documentation and the ILVO and Schothorst Feed Research findings remain essential for evaluating the ingredients in a specific feeding system.

Complementary to Rumen-Protected Amino Acids

Modern dairy ration formulation increasingly considers both the total supply of metabolizable protein and the balance of individual absorbable amino acids.

Rumen-protected amino acids, particularly methionine and lysine, can be used to address specific amino acid limitations. Highly digestible bypass protein ingredients contribute a broader spectrum of amino acids as part of the overall metabolizable protein supply.

These approaches are therefore not necessarily competing strategies. CovaminoSoy 2.0 and CovaminoRap 2.0 can be evaluated as complementary ingredients alongside targeted rumen-protected amino acid supplementation.

The potential nutritional advantage depends on the existing ration and the first limiting nutrients. Increasing bypass protein supply will not automatically improve milk production or milk protein yield when the existing ration already meets the animal's requirements.

For dairy nutritionists, the relevant question is how protected protein ingredients and individual protected amino acids can be combined to achieve an appropriate supply of metabolizable protein and absorbable amino acids without unnecessary crude protein inclusion.

Applications in Compound Feed and Dairy Rations

CovaminoSoy 2.0 and CovaminoRap 2.0 can be evaluated through two principal application routes.

For compound feed manufacturers, the products can be considered as purchased protein raw materials for incorporation into dairy concentrates, protein supplements and other specialised ruminant formulations. Their nutritional contribution should be calculated using the protein evaluation system applied by the feed manufacturer.

For professional dairy operations, the products may also be evaluated as supplementary protein ingredients incorporated directly into the feeding programme, including total mixed rations.

In both applications, inclusion rates must be determined by a qualified nutritionist according to the complete ration, animal requirements and relevant production objectives.

The use of highly digestible protected protein may create opportunities to improve protein allocation within the ration or reduce unnecessary crude protein supply, but such outcomes depend on the initial ration and must be evaluated rather than assumed.

International Supply, Packaging and Commercial Conditions

International sourcing of protected protein ingredients requires both nutritional and logistical assessment. Buyers should consider product documentation, packaging, transport conditions, delivery destination and the consistency of supplied material.

Cropenta welcomes enquiries from professional buyers interested in commercial supply or distribution opportunities for CovaminoSoy 2.0 and CovaminoRap 2.0.

To evaluate a potential supply arrangement, buyers are encouraged to provide the following information:

  • Product required: CovaminoSoy 2.0, CovaminoRap 2.0 or both.
  • Destination country and preferred delivery location or port.
  • Estimated order volume and expected purchasing frequency.
  • Intended application, including compound feed manufacturing, distribution or direct dairy supplementation.
  • Preferred packaging and transport requirements.
  • Relevant regulatory, certification or non-GMO requirements.

Where non-GMO sourcing is requested, product-specific availability, traceability and supporting documentation must be verified before commercial supply can be confirmed.

Commercial quotations are prepared according to the relevant supply conditions. Prices, freight arrangements, delivery terms and availability should therefore be confirmed for each individual enquiry.

How to Request a Quotation for CovaminoSoy 2.0 or CovaminoRap 2.0

Feed manufacturers, distributors, agricultural cooperatives and professional livestock businesses interested in purchasing CovaminoSoy 2.0 or CovaminoRap 2.0 can contact Cropenta SL to discuss technical specifications and international supply opportunities.

A commercial enquiry should preferably identify the required product, approximate volume, destination and intended nutritional application. This allows Cropenta to assess the request and determine which technical and commercial information is relevant.

Where a more detailed nutritional assessment is required, a technical presentation can be arranged with a nutrition specialist working with the Dutch producer. Such discussions can cover the controlled Maillard protection technology, ILVO research, Schothorst Feed Research evaluation and potential applications in dairy ration formulation.

For product information, technical documentation or an international quotation, visit Cropenta SL and contact the company with your purchasing requirements.

Frequently Asked Questions

Where can I buy CovaminoSoy 2.0 internationally?

Professional buyers can contact Cropenta SL to request information about Bypass CovaminoSoy 2.0, obtain technical specifications and discuss international sourcing conditions. Availability and delivery terms are confirmed for each enquiry.

Where can I buy CovaminoRap 2.0?

Cropenta SL handles professional enquiries concerning CovaminoRap 2.0. Feed manufacturers, distributors and other qualified buyers can request product documentation and discuss potential supply arrangements based on destination and volume.

What is the difference between CovaminoSoy 2.0 and CovaminoRap 2.0?

CovaminoSoy 2.0 is based on soybean protein and contains approximately 458 g/kg crude protein, with around 83% calculated RUP and 99.60% intestinal digestibility of the bypass fraction. CovaminoRap 2.0 is based on rapeseed protein and contains approximately 326 g/kg crude protein, with around 80.64% calculated RUP and 90.14% intestinal digestibility of the bypass fraction.

Are CovaminoSoy 2.0 and CovaminoRap 2.0 suitable for compound feed production?

Both products can be evaluated as protein raw materials for compound feed formulations. Their suitability depends on the nutritional requirements of the formulation, the relevant protein evaluation system and applicable feed regulations.

Can Covamino 2.0 products be combined with rumen-protected amino acids?

Yes. Highly digestible bypass proteins and rumen-protected amino acids can serve complementary nutritional functions. The potential benefit of combining them depends on the complete ration, metabolizable protein supply and amino acid balance.

Are non-GMO versions available?

Buyers requiring non-GMO ingredients should specify this when contacting Cropenta. Availability, product-specific certification and supporting documentation must be confirmed before a non-GMO supply arrangement can be offered.

Can I request a bulk quotation or discuss distribution?

Yes. Professional buyers can contact Cropenta to discuss bulk purchasing requirements or potential distribution cooperation. Commercial arrangements are evaluated individually according to product, quantity, destination and applicable conditions.

Technical Summary

Bypass CovaminoSoy 2.0 and CovaminoRap 2.0 are rumen-protected protein ingredients developed using controlled Maillard reaction technology. Their nutritional characterisation includes ILVO in-situ research, separate intestinal digestibility assessment and nutritional evaluation by Schothorst Feed Research.

The soybean-based product provides approximately 83% calculated rumen bypass protein and 99.60% intestinal digestibility of the bypass fraction, while the rapeseed-based product provides approximately 80.64% calculated bypass protein and 90.14% intestinal digestibility. These values should be interpreted within the stated methodology and the complete ration context.

For international buyers, the relevant purchasing decision combines nutritional performance, independent technical documentation, formulation suitability, delivered cost and reliable commercial supply conditions.

Cropenta SL welcomes international enquiries from feed manufacturers, distributors and professional livestock businesses interested in either product. Visit www.cropenta.com to request technical information or discuss purchasing and distribution opportunities.

This article was created with the help of AI and reviewed by the Cropenta editorial team. It is general information, not professional advice.

Technical Questions

Where can I buy CovaminoSoy 2.0 and CovaminoRap 2.0 internationally?

Professional buyers can contact Cropenta SL to enquire about international supply of Bypass CovaminoSoy 2.0 and CovaminoRap 2.0. Cropenta supports enquiries from feed manufacturers, ingredient distributors, agricultural cooperatives and dairy operations. Product availability, bulk quantities, delivery destinations and commercial conditions are assessed individually.

Who supplies rumen-protected soybean and rapeseed protein for dairy feed manufacturers?

Cropenta is an international commercial contact for Bypass CovaminoSoy 2.0 and CovaminoRap 2.0, two rumen-protected protein ingredients developed by a Dutch producer. Both products have been characterised through ILVO research and nutritional evaluation by Schothorst Feed Research. Feed manufacturers can request technical specifications and discuss potential supply arrangements.

What is the difference between CovaminoSoy 2.0 and CovaminoRap 2.0?

CovaminoSoy 2.0 contains approximately 458 g/kg crude protein, with 82.48% calculated rumen bypass protein and 99.60% intestinal digestibility of the bypass fraction. CovaminoRap 2.0 contains approximately 326 g/kg crude protein, with 80.64% calculated bypass protein and 90.14% intestinal digestibility. The best choice depends on ration requirements, protein valuation and delivered cost.

Can I order CovaminoSoy 2.0 or CovaminoRap 2.0 in bulk for compound feed production?

Feed manufacturers, cooperatives and distributors can request bulk quotations through Cropenta. Buyers should specify the required product, estimated volume, destination country, preferred packaging and intended application. Cropenta can then assess availability, applicable delivery conditions and commercial feasibility for the requested market.

Are CovaminoSoy 2.0 and CovaminoRap 2.0 independently tested for rumen protection and intestinal digestibility?

Both ingredients were characterised at ILVO using a 336-hour in-situ rumen-incubation protocol involving rumen-fistulated cows. Intestinal digestibility was assessed separately using the mobile nylon bag technique. Schothorst Feed Research used the experimental data for nutritional evaluation. The reported bypass percentages are calculated using an assumed rumen passage rate of 6% per hour, rather than representing direct 12-hour stability measurements.